Squarepoint’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-45,054
| Closed | -$330K | – | 3070 |
|
2025
Q1 | $330K | Buy |
+45,054
| New | +$330K | ﹤0.01% | 2145 |
|
2024
Q4 | – | Sell |
-22,478
| Closed | -$196K | – | 3095 |
|
2024
Q3 | $196K | Sell |
22,478
-42,433
| -65% | -$369K | ﹤0.01% | 2180 |
|
2024
Q2 | $444K | Buy |
64,911
+47,614
| +275% | +$326K | ﹤0.01% | 1787 |
|
2024
Q1 | $157K | Buy |
17,297
+3,353
| +24% | +$30.5K | ﹤0.01% | 2160 |
|
2023
Q4 | $62.2K | Buy |
+13,944
| New | +$62.2K | ﹤0.01% | 2343 |
|
2023
Q3 | – | Sell |
-13,689
| Closed | -$70.6K | – | 2729 |
|
2023
Q2 | $70.6K | Buy |
+13,689
| New | +$70.6K | ﹤0.01% | 2256 |
|
2022
Q4 | – | Sell |
-17,291
| Closed | -$72K | – | 2529 |
|
2022
Q3 | $72K | Sell |
17,291
-19,600
| -53% | -$81.6K | ﹤0.01% | 1924 |
|
2022
Q2 | $148K | Buy |
+36,891
| New | +$148K | ﹤0.01% | 1808 |
|
2021
Q4 | – | Sell |
-19,913
| Closed | -$199K | – | 2734 |
|
2021
Q3 | $199K | Sell |
19,913
-14,768
| -43% | -$148K | ﹤0.01% | 1829 |
|
2021
Q2 | $492K | Buy |
34,681
+14,655
| +73% | +$208K | ﹤0.01% | 1615 |
|
2021
Q1 | $329K | Buy |
20,026
+9,711
| +94% | +$160K | ﹤0.01% | 1817 |
|
2020
Q4 | $214K | Sell |
10,315
-106,531
| -91% | -$2.21M | ﹤0.01% | 2091 |
|
2020
Q3 | $889K | Sell |
116,846
-32,411
| -22% | -$247K | 0.01% | 1008 |
|
2020
Q2 | $1.24M | Buy |
149,257
+123,833
| +487% | +$1.03M | 0.02% | 824 |
|
2020
Q1 | $126K | Buy |
+25,424
| New | +$126K | ﹤0.01% | 1588 |
|
2019
Q4 | – | Sell |
-14,348
| Closed | -$44K | – | 2589 |
|
2019
Q3 | $44K | Buy |
+14,348
| New | +$44K | ﹤0.01% | 2148 |
|
2018
Q1 | – | Sell |
-22,243
| Closed | -$99K | – | 1999 |
|
2017
Q4 | $99K | Buy |
+22,243
| New | +$99K | ﹤0.01% | 1952 |
|
2017
Q3 | – | Sell |
-15,703
| Closed | -$146K | – | 1787 |
|
2017
Q2 | $146K | Buy |
+15,703
| New | +$146K | ﹤0.01% | 1356 |
|
2017
Q1 | – | Sell |
-60,985
| Closed | -$510K | – | 1798 |
|
2016
Q4 | $510K | Buy |
+60,985
| New | +$510K | 0.02% | 816 |
|